INST Phase II Trial of Gemcitabine and Irinotecan in Patients With Relapsed or Refractory Lymphoma.
Clinical trial NCT00276003 · COMPLETED
Trial details
- NCT number
- NCT00276003
- Sponsor
- University of New Mexico
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-08-01
- Primary completion
- 2005-06-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.